Table 3.
Clinical characteristics of patients who received CIT for ≥ 3 courses or < 3 courses
| Clinical features | CIT ≥ 3 courses | CIT < 3 courses | P-value |
|---|---|---|---|
| Sex | |||
| Male | 11 | 11 | 0.187 |
| Female | 6 | 1 | |
| Age, years | |||
| Median (range) | 61 (41–79) | 64 (54–78) | 0.107 |
| Smoking index | |||
| Median (range) | 400 (0–1000) | 350 (0–2000) | 0.751 |
| ECOG | |||
| ≤1 | 16 | 9 | 0.279 |
| 2 | 1 | 3 | |
| Chemotherapy courses | |||
| Median | 6 | 6 | 0.713 |
| Range | 4–6 | 4–6 | |
| Radiotherapy | |||
| Yes | 16 | 9 | 0.279 |
| No | 1 | 3 | |
| Surgery | |||
| Yes | 3 | 1 | 0.622 |
| No | 14 | 11 | |
| Chemotherapy responses * | |||
| CR | 5 | 2 | 0.707 |
| PR | 7 | 7 | |
| SD | 5 | 3 | |
| Stage | |||
| Limited | 10 | 7 | 1.000 |
| Extensive | 7 | 5 | |
Abbreviations: CIT, cellular immunotherapy; ECOG, Eastern Cooperative Oncology Group; CR, complete remission; PR, partial remission; SD, stable disease
Note: *The responses for the first-line therapy